{"blog": [], "keywords": [{"value": "Radius Health Inc.", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Osteoporosis", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Eli Lilly and Company", "name": "organizations", "rank": "4", "is_major": "Y"}, {"value": "Bisphosphonates (Drugs)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Journal of the American Medical Assn", "name": "organizations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/08/17/health/osteoporosis-a-disease-with-few-treatment-options-may-soon-have-one-more.html", "document_type": "article", "byline": {"person": [{"lastname": "KOLATA", "firstname": "Gina", "role": "reported", "organization": "", "rank": 1}], "original": "By GINA KOLATA"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-thumbWide.jpg", "legacy": {"wide": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-articleLarge.jpg", "xlargeheight": "181", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 181}, {"url": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/16/science/16BONE-COMBO/16BONE-COMBO-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "1348", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "A clinical trial found that a new drug stimulates bone growth and prevents fractures at least as well as the only other such drug on the market.", "pub_date": "2016-08-17T04:00:00+0000", "news_desk": "National", "headline": {"print_headline": "Osteoporosis, a Disease With Few Treatment Choices, May Soon Have Another", "main": "Osteoporosis, a Disease With Few Treatment Options, May Soon Have One More"}, "print_page": "10", "snippet": "A clinical trial found that a new drug stimulates bone growth and prevents fractures at least as well as the only other such drug on the market....", "_id": "57b32a7c95d0e021d7980f3d", "slideshow_credits": null, "abstract": "Results of clinical trial conducted by Radius Health Inc, published in JAMA, find company's new osteoporosis drug stimulates bone growth and prevents fractures at least as well as Eli Lily's Forteo, only other such drug on market; drug from Radius, which costs less than Forteo, is expected to be approved by federal regulators "}